Last updated: 20 June 2024 at 4:26pm EST

Nancy Thornberry Net Worth




The estimated Net Worth of Nancy Thornberry is at least $613 millier dollars as of 22 May 2023. Ms. Thornberry owns over 14,850 units of Schrodinger stock worth over $305,613 and over the last 5 years she sold SDGR stock worth over $0. In addition, she makes $307,588 as Independent Director at Schrodinger.

Ms. Thornberry SDGR stock SEC Form 4 insiders trading

Nancy has made over 2 trades of the Schrodinger stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 14,850 units of SDGR stock worth $171,072 on 22 May 2023.

The largest trade she's ever made was exercising 14,850 units of Schrodinger stock on 22 May 2023 worth over $171,072. On average, Nancy trades about 1,414 units every 20 days since 2020. As of 22 May 2023 she still owns at least 14,850 units of Schrodinger stock.

You can see the complete history of Ms. Thornberry stock trades at the bottom of the page.





Nancy Thornberry biography

Nancy Thornberry serves as Independent Director of the Company. Ms. Thornberry has served as chief executive officer of Kallyope, Inc., a biotechnology company, since November 2015. Between August 2013 and October 2015, Ms. Thornberry was self-employed as a consultant to companies in the biotechnology and pharmaceutical industries. Prior to that, Ms. Thornberry spent over 30 years at Merck, a pharmaceutical company, where she held a variety of positions including senior vice president and franchise head, diabetes and endocrinology, from April 2011 to July 2013, senior vice president and franchise head, diabetes and obesity, from September 2009 to April 2011, vice president, worldwide basic research head, diabetes and obesity, from February 2007 to September 2009 and executive director, metabolic disorders, from 2004 to February 2007, among other positions. Ms. Thornberry received a B.S. in Chemistry and Biology from Muhlenberg College.

What is the salary of Nancy Thornberry?

As the Independent Director of Schrodinger, the total compensation of Nancy Thornberry at Schrodinger is $307,588. There are 8 executives at Schrodinger getting paid more, with Dr. Ramy Farid Ph.D. having the highest compensation of $1,010,921.



How old is Nancy Thornberry?

Nancy Thornberry is 63, she's been the Independent Director of Schrodinger since 2019. There are 3 older and 19 younger executives at Schrodinger. The oldest executive at Schrodinger, Inc. is Dr. Richard A. Friesner, 68, who is the Co-Founder, Scientific Advisory Chairman and Director.

What's Nancy Thornberry's mailing address?

Nancy's mailing address filed with the SEC is C/O SCHRODINGER, INC.,, 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036.

Insiders trading at Schrodinger

Over the last 5 years, insiders at Schrodinger have traded over $1,009,056,149 worth of Schrodinger stock and bought 838,235 units worth $14,249,995 . The most active insiders traders include & Melinda Gates Foundation ..., David E Schrodinger Equity ... et Michael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of $2,459,207. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth $24,191.



What does Schrodinger do?

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.



Complete history of Ms. Thornberry stock trades at Vertex Pharmaceuticals, Denali Therapeutics Inc et Schrodinger

Initié
Trans.
Transaction
Prix ​​total
Nancy Thornberry
Directeur
Exercice d'option $171,072
22 May 2023
Nancy Thornberry
Directeur
Exercice d'option $57,024
11 Aug 2022


Schrodinger executives and stock owners

Schrodinger executives and other stock owners filed with the SEC include: